A citation-based method for searching scientific literature

Abhishek Chatterjee, Madan Maitre, Archya Dasgupta, Epari Sridhar, Tejpal Gupta. Methods Mol Biol 2022
Times Cited: 1







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Inter and intra-tumoral heterogeneity as a platform for personalized therapies in medulloblastoma.
Marina Danilenko, Steven C Clifford, Edward C Schwalbe. Pharmacol Ther 2021
3
100

Molecular Subgroup Is the Strongest Predictor of Medulloblastoma Outcome in a Resource-Limited Country.
Nisreen Amayiri, Maisa Swaidan, Ahmed Ibrahimi, Nader Hirmas, Awni Musharbash, Eric Bouffet, Maysa Al-Hussaini, Vijay Ramaswamy. JCO Glob Oncol 2021
5
100

A simplified approach using Taqman low-density array for medulloblastoma subgrouping.
Gustavo Alencastro Veiga Cruzeiro, Karina Bezerra Salomão, Carlos Alberto Oliveira de Biagi, Martin Baumgartner, Dominik Sturm, Régia Caroline Peixoto Lira, Taciani de Almeida Magalhães, Mirella Baroni Milan, Vanessa da Silva Silveira, Fabiano Pinto Saggioro,[...]. Acta Neuropathol Commun 2019
13
100


Immunohistochemical and nanoString-Based Subgrouping of Clinical Medulloblastoma Samples.
Colleen E D'Arcy, Liana Figueiredo Nobre, Anthony Arnaldo, Vijay Ramaswamy, Michael D Taylor, Lili Naz-Hazrati, Cynthia E Hawkins. J Neuropathol Exp Neurol 2020
10
100

Classifying Medulloblastoma Subgroups Based on Small, Clinically Achievable Gene Sets.
Sivan Gershanov, Shreyas Madiwale, Galina Feinberg-Gorenshtein, Igor Vainer, Tamar Nehushtan, Shalom Michowiz, Nitza Goldenberg-Cohen, Yehudit Birger, Helen Toledano, Mali Salmon-Divon. Front Oncol 2021
2
100

Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomas.
Marcel Kool, Andrey Korshunov, Marc Remke, David T W Jones, Maria Schlanstein, Paul A Northcott, Yoon-Jae Cho, Jan Koster, Antoinette Schouten-van Meeteren, Dannis van Vuurden,[...]. Acta Neuropathol 2012
619
100

Prognostic effect of whole chromosomal aberration signatures in standard-risk, non-WNT/non-SHH medulloblastoma: a retrospective, molecular analysis of the HIT-SIOP PNET 4 trial.
Tobias Goschzik, Edward C Schwalbe, Debbie Hicks, Amanda Smith, Anja Zur Muehlen, Dominique Figarella-Branger, François Doz, Stefan Rutkowski, Birgitta Lannering, Torsten Pietsch,[...]. Lancet Oncol 2018
39
100

Intertumoral Heterogeneity within Medulloblastoma Subgroups.
Florence M G Cavalli, Marc Remke, Ladislav Rampasek, John Peacock, David J H Shih, Betty Luu, Livia Garzia, Jonathon Torchia, Carolina Nor, A Sorana Morrissy,[...]. Cancer Cell 2017
523
100

A Summary of the Inaugural WHO Classification of Pediatric Tumors: Transitioning from the Optical into the Molecular Era.
Stefan M Pfister, Miguel Reyes-Múgica, John K C Chan, Henrik Hasle, Alexander J Lazar, Sabrina Rossi, Andrea Ferrari, Jason A Jarzembowski, Kathy Pritchard-Jones, D Ashley Hill,[...]. Cancer Discov 2022
6
100

The role of angiogenesis in Group 3 medulloblastoma pathogenesis and survival.
Eric M Thompson, Stephen T Keir, Talaignair Venkatraman, Christopher Lascola, Kristen W Yeom, Andrew B Nixon, Yingmiao Liu, Daniel Picard, Marc Remke, Darell D Bigner,[...]. Neuro Oncol 2017
36
100

Long non-coding RNAs as a predictive markers of group 3 medulloblastomas.
Melis Mutlu, Cagla Tekin, Secil Ak Aksoy, Mevlut Ozgur Taskapilioglu, Seckin Kaya, Rabia Nur Balcin, Pınar Eser Ocak, Hasan Kocaeli, Ahmet Bekar, Sahsine Tolunay,[...]. Neurol Res 2022
2
100

Second-generation molecular subgrouping of medulloblastoma: an international meta-analysis of Group 3 and Group 4 subtypes.
Tanvi Sharma, Edward C Schwalbe, Daniel Williamson, Martin Sill, Volker Hovestadt, Martin Mynarek, Stefan Rutkowski, Giles W Robinson, Amar Gajjar, Florence Cavalli,[...]. Acta Neuropathol 2019
96
100

Medulloblastomics revisited: biological and clinical insights from thousands of patients.
Volker Hovestadt, Olivier Ayrault, Fredrik J Swartling, Giles W Robinson, Stefan M Pfister, Paul A Northcott. Nat Rev Cancer 2020
69
100

Medulloblastoma comprises four distinct molecular variants.
Paul A Northcott, Andrey Korshunov, Hendrik Witt, Thomas Hielscher, Charles G Eberhart, Stephen Mack, Eric Bouffet, Steven C Clifford, Cynthia E Hawkins, Pim French,[...]. J Clin Oncol 2011
861
100

Identification of ITPR1 as a Hub Gene of Group 3 Medulloblastoma and Coregulated Genes with Potential Prognostic Values.
Pablo Ferreira das Chagas, Graziella Ribeiro de Sousa, Luciana Chain Veronez, Andrea Martins-da-Silva, Carolina Alves Pereira Corrêa, Gustavo Alencastro Veiga Cruzeiro, Luis Fernando Peinado Nagano, Rosane Gomes de Paula Queiroz, Suely Kazue Nagahashi Marie, Silvia Regina Brandalise,[...]. J Mol Neurosci 2022
2
100

Cytogenetic prognostication within medulloblastoma subgroups.
David J H Shih, Paul A Northcott, Marc Remke, Andrey Korshunov, Vijay Ramaswamy, Marcel Kool, Betty Luu, Yuan Yao, Xin Wang, Adrian M Dubuc,[...]. J Clin Oncol 2014
176
100

Specification of diverse cell types during early neurogenesis of the mouse cerebellum.
John W Wizeman, Qiuxia Guo, Elliott M Wilion, James Yh Li. Elife 2019
33
100

FSTL5 is a marker of poor prognosis in non-WNT/non-SHH medulloblastoma.
Marc Remke, Thomas Hielscher, Andrey Korshunov, Paul A Northcott, Sebastian Bender, Marcel Kool, Frank Westermann, Axel Benner, Huriye Cin, Marina Ryzhova,[...]. J Clin Oncol 2011
125
100

Neoplastic and immune single-cell transcriptomics define subgroup-specific intra-tumoral heterogeneity of childhood medulloblastoma.
Kent A Riemondy, Sujatha Venkataraman, Nicholas Willard, Anandani Nellan, Bridget Sanford, Andrea M Griesinger, Vladimir Amani, Siddhartha Mitra, Todd C Hankinson, Michael H Handler,[...]. Neuro Oncol 2022
10
100

Rnd3/RhoE Is down-regulated in hepatocellular carcinoma and controls cellular invasion.
Florence Grise, Sandra Sena, Aurélien Bidaud-Meynard, Jessica Baud, Jean-Baptiste Hiriart, Kassem Makki, Nathalie Dugot-Senant, Cathy Staedel, Paulette Bioulac-Sage, Jessica Zucman-Rossi,[...]. Hepatology 2012
47
100

Outcome prediction in pediatric medulloblastoma based on DNA copy-number aberrations of chromosomes 6q and 17q and the MYC and MYCN loci.
Stefan Pfister, Marc Remke, Axel Benner, Frank Mendrzyk, Grischa Toedt, Jörg Felsberg, Andrea Wittmann, Frauke Devens, Nicolas U Gerber, Stefan Joos,[...]. J Clin Oncol 2009
220
100

The whole-genome landscape of medulloblastoma subtypes.
Paul A Northcott, Ivo Buchhalter, A Sorana Morrissy, Volker Hovestadt, Joachim Weischenfeldt, Tobias Ehrenberger, Susanne Gröbner, Maia Segura-Wang, Thomas Zichner, Vasilisa A Rudneva,[...]. Nature 2017
484
100

Discovery of KIRREL as a biomarker for prognostic stratification of patients with thin melanoma.
Sebastian Lundgren, Helena Fagerström-Vahman, Cheng Zhang, Liv Ben-Dror, Adil Mardinoglu, Mathias Uhlen, Björn Nodin, Karin Jirström. Biomark Res 2019
9
100

Novel molecular subgroups for clinical classification and outcome prediction in childhood medulloblastoma: a cohort study.
Edward C Schwalbe, Janet C Lindsey, Sirintra Nakjang, Stephen Crosier, Amanda J Smith, Debbie Hicks, Gholamreza Rafiee, Rebecca M Hill, Alice Iliasova, Thomas Stone,[...]. Lancet Oncol 2017
269
100

Molecular subgroups of medulloblastoma: the current consensus.
Michael D Taylor, Paul A Northcott, Andrey Korshunov, Marc Remke, Yoon-Jae Cho, Steven C Clifford, Charles G Eberhart, D Williams Parsons, Stefan Rutkowski, Amar Gajjar,[...]. Acta Neuropathol 2012
100

Risk stratification of childhood medulloblastoma in the molecular era: the current consensus.
Vijay Ramaswamy, Marc Remke, Eric Bouffet, Simon Bailey, Steven C Clifford, Francois Doz, Marcel Kool, Christelle Dufour, Gilles Vassal, Till Milde,[...]. Acta Neuropathol 2016
317
100

Novel Molecular Hallmarks of Group 3 Medulloblastoma by Single-Cell Transcriptomics.
Chaoying Qin, Yimin Pan, Yuzhe Li, Yue Li, Wenyong Long, Qing Liu. Front Oncol 2021
2
100

Clinically Tractable Outcome Prediction of Non-WNT/Non-SHH Medulloblastoma Based on TPD52 IHC in a Multicohort Study.
Alberto Delaidelli, Christopher Dunham, Mariarita Santi, Gian Luca Negri, Joanna Triscott, Olga Zheludkova, Andrey Golanov, Marina Ryzhova, Konstantin Okonechnikov, Daniel Schrimpf,[...]. Clin Cancer Res 2022
1
100

Desmoplastic/nodular medulloblastomas (DNMB) and medulloblastomas with extensive nodularity (MBEN) disclose similar epigenetic signatures but different transcriptional profiles.
Andrey Korshunov, Felix Sahm, Konstantin Okonechnikov, Marina Ryzhova, Damian Stichel, Daniel Schrimpf, Belen Casalini, Philipp Sievers, Jochen Meyer, Olga Zheludkova,[...]. Acta Neuropathol 2019
3
100

Simplified Molecular Subtyping of Medulloblastoma for Reduced Cost and Improved Turnaround Time.
Somruetai Shuangshoti, Paveen Tadadontip, Piti Techavichit, Paul S Thorner, Shanop Shuangshoti, Chinachote Teerapakpinyo. Appl Immunohistochem Mol Morphol 2020
6
100

Novel genetic features of human and mouse Purkinje cell differentiation defined by comparative transcriptomics.
David E Buchholz, Thomas S Carroll, Arif Kocabas, Xiaodong Zhu, Hourinaz Behesti, Phyllis L Faust, Lauren Stalbow, Yin Fang, Mary E Hatten. Proc Natl Acad Sci U S A 2020
10
100

Genomic and Transcriptomic Analyses Reveals ZNF124 as a Critical Regulator in Highly Aggressive Medulloblastomas.
Zaili Luo, Xinran Dong, Jianzhong Yu, Yong Xia, Kalen P Berry, Rohit Rao, Lingli Xu, Ping Xue, Tong Chen, Yifeng Lin,[...]. Front Cell Dev Biol 2021
4
100


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.